CoChat

Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma

Open access
Fabrizio, Federico Pio, Costantini, Manuela, Copetti, Massimiliano, la Torre, Annamaria, Sparaneo, Angelo, Fontana, Andrea, Poeta, Luana, Gallucci, Michele, Sentinelli, Steno, Graziano, Paolo, Parente, Paola, Pompeo, Vincenzo, Salvo, Laura De, Simone, Giuseppe, Papalia, Rocco, Picardo, Francesco, Balsamo, Teresa, Flammia, Gerardo Paolo, Trombetta, Domenico, Pantalone, Angela, Kok, Klaas, Paranita, Ferronika, Muscarella, Lucia Anna, Fazio, Vito Michele · 2017 · Oncotarget
Cited by 87

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

// Federico Pio Fabrizio 1, * , Manuela Costantini 2, 5, 4, * , Massimiliano Copetti 3 , Annamaria la Torre 1 , Angelo Sparaneo 1 , Andrea Fontana 3 , Luana Poeta 4 , Michele Gallucci 5 , Steno Sentinelli 6 , Paolo Graziano 7 , Paola Parente 7 , Vincenzo Pompeo 5 , Laura De Salvo 6 , Giuseppe Simone 5 , Rocco Papalia 5 , Francesco Picardo 2 , Teresa Balsamo 1 , Gerardo Paolo Flammia 8 , Domenico Trombetta 1 , Angela Pantalone 2 , Klaas Kok 9 , Ferronika Paranita 9 , Lucia Anna Muscarella 1, * , Vito Michele Fazio 1, 2, * 1 Laboratory of Oncology, IRCCS “Casa Sollievo della Sofferenza” Hospital, San Giovanni Rotondo, Italy 2 Genetic and Clinic Pathology Unit, University Campus Bio-Medico of Rome, Rome, Italy 3 Unit of Biostatistics, IRCCS “Casa Sollievo della Sofferenza” Hospital, San Giovanni Rotondo, Italy 4 Department of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, Bari, Italy 5 Department of Urology, Regina Elena National Cancer Institute, Rome, Italy 6 Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy 7 Unit of Pathology, IRCCS “Casa Sollievo della Sofferenza” Hospital, San Giovanni Rotondo, Italy 8 UOC of Urology, Campus Bio-Medico University Hospital, Rome, Italy 9 Department of Genetics, University of Groningen, University Medical Center Groningen, The Netherlands * These authors equally contributed to this work Correspondence to: Lucia Anna Muscarella, email: l.muscarella@operapadrepio.it Keywords: ccRCC, KEAP1, methylation, epigenetic biomarker, outcome Received: June 13, 2016 Accepted: December 27, 2016 Published: January 04, 2017 ABSTRACT The Keap1/Nrf2 pathway is a master regulator of the cellular redox state through the induction of several antioxidant defence genes implicated in chemotherapeutic drugs resistance of tumor cells. An increasing body of evidence supports a key role for Keap1/Nrf2 pathway in kidney diseases and renal cell carcinoma (RCC), but data concerning the molecular basis and the clinical effect of its deregulation remain incomplete. Here we present a molecular profiling of the KEAP1 and NFE2L2 genes in five different Renal Cell Carcinoma histotypes by analysing 89 tumor/normal paired tissues (clear cell Renal Carcinoma, ccRCCs; Oncocytomas; Papillary Renal Cell Carcinoma Type 1, PRCC1; Papillary Renal Cell Carcinoma Type 2, PRCC2; and Chromophobe Cell Carcinoma). A tumor-specific DNA methylation of the KEAP1 gene promoter region was found as a specific feature of the ccRCC subtype (18/37, 48.6%) and a direct correlation with mRNA levels was confirmed by in vitro 5-azacytidine treatment. Analysis of an independent data set of 481 ccRCC and 265 PRCC tumors corroborates our results and multivariate analysis reveals a significant correlation among ccRCCs epigenetic KEAP1 silencing and staging, grading and overall survival. Our molecular results show for the the first time the epigenetic silencing of KEAP1 promoter as the leading mechanism for modulation of KEAP1 expression in ccRCCs and corroborate the driver role of Keap1/Nrf2 axis deregulation with potential new function as independent epigenetic prognostic marker in renal cell carcinoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.14492

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 87

Metadata

Authors
Fabrizio, F. P., Costantini, M., Copetti, M., la Torre, A., Sparaneo, A., Fontana, A., Poeta, L., Gallucci, M., Sentinelli, S., Graziano, P., Parente, P., Pompeo, V., Salvo, L. D., Simone, G., Papalia, R., Picardo, F., Balsamo, T., Flammia, G. P., Trombetta, D., Pantalone, A., Kok, K., Paranita, F., Muscarella, L. A., & Fazio, V. M.
Venue
Oncotarget
Published
2017-01-04
Volume
8
Issue
7
Pages
11187-11198
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2567958491
Cited by
87
References
6
FWCI
4.27
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.